Updated Jul 16, 2026
Syage Jack has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Syage Jack is listed as a director of Entero Therapeutics, Inc. based on the SEC filing dated 2026-06-04. Publicly available information on his professional background, education, or other board roles is not readily accessible in widely used sources. The name may appear in various orderings (e.g., Jack Syage) in corporate records, and there is no confirmed additional role noted here. This entry reflects the SEC context and may not capture a complete biographical profile.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | GRDX | GridAI Technologies Corp. | A — Grant or award | 40.0K | $0.00 |
Syage Jack is listed as a director of Entero Therapeutics, Inc. based on the SEC filing dated 2026-06-04. Publicly available information on his professional background, education, or other board roles is not readily accessible in widely used sources. The name may appear in various orderings (e.g., Jack Syage) in corporate records, and there is no confirmed additional role noted…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Syage Jack profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.